Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs-Influence of Smoking Behavior and Inflammation on Pharmacokinetics

• المؤلفون الرئيسيون: Nicole Moschny (مؤلف), Gudrun Hefner (مؤلف), Renate Grohmann (مؤلف), Gabriel Eckermann (مؤلف), Hannah B Maier (مؤلف), Johanna Seifert (مؤلف), Johannes Heck (مؤلف), Flverly Francis (مؤلف), Stefan Bleich (مؤلف), Sermin Toto (مؤلف), Catharina Meissner (مؤلف)
• التنسيق: كتاب
• منشور في: MDPI AG, 2021-05-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Both inflammation and smoking can influence a drug's pharmacokinetic properties, i.e., its liberation, absorption, distribution, metabolism, and elimination. Depending on, e.g., pharmacogenetics, these changes may alter treatment response or cause serious adverse drug reactions and are thus of...